Bruce Car - Oct 3, 2022 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Role
Chief Scientific Officer
Signature
/s/ George Clark, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
Oct 3, 2022
Transactions value $
$0
Form type
4
Date filed
10/5/2022, 05:40 PM
Previous filing
Oct 5, 2022
Next filing
Nov 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Stock Options (Right to Buy) Award $0 +300K $0.00 300K Oct 3, 2022 Common Shares 300K $7.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in four equal installments on October 3, 2022, 2023, 2024, and 2025, subject to the Reporting Person's continuous service with the Issuer at each vesting date.